Humanized antibody to the alpha4beta7 integrin for induction of remission in ulcerative colitis

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Behm, Brian W ^b   Bickston, Stephen J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Antibodies, monoclonal adverse effects; *therapeutic use ; Colitis, ulcerative *therapy ; Humans; Integrins *immunology ; Remission induction

Indexed keywords

ALPH4BETA7 INTEGRIN; INTEGRIN; MLN 02; NEUTRALIZING ANTIBODY; PLACEBO; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; ANTIBODY RESPONSE; ANTIBODY TITER; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNOGENICITY; INSTILLATION SITE IRRITATION; META ANALYSIS; NAUSEA; PNEUMONIA; QUALITY OF LIFE; REMISSION; REVIEW; SIDE EFFECT; SIGMOIDOSCOPY; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS; URTICARIA;

EID: 67649436889     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007571     Document Type: Review

References (13)

1. Feagan BG, Greenberg GR,Wild G, Fedorak RN, Paré P, McDonald JW, et al.Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl JMed 2005;352(24):2499-2507 (Pubitemid 41007865)
2. Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2006, Issue 3. [Art. No.: CD005112. DOI: 10.1002/14651858. CD005112.pub2]
3. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964;1(5375):89-92.
4. Erle DJ, Briskin MJ, Butcher EC, Garcia-Pardo A, Lazarovits AI, Tidswell M. Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. J Immunol 1994;153 (2):517-528 (Pubitemid 24206281)
5. Feagan B, McDonald JWD, Greenberg G, Wild G, Pare P, Fedorak R, et al.An ascending dose trial of a humanised a4b7 antibody in ulcerative colitis (UC). Gastroenterology 2000;118(Suppl 2):A874.
6. Hesterberg PE,Winsor-Hines D, BriskinMJ, Soler-Ferran D,Merrill C,Mackay CR, et al.Rapid resolution of chronic colitis in the cottontop tamarin with an antibody to a gut-homing integrin alpha 4 beta 7. Gastroenterology 1996;111(5):1373-1380
7. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updatedMay 2005]. In: The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd., 2005.
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996;17(1):1-12. (Pubitemid 26120810)
9. MacDonald JK, McDonald JWD. Natalizumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2007, Issue 1. [Art. No.: CD006097. DOI: 10.1002/14651858.CD006097.pub2]
10. Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, et al.Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med 2005;353(18):1912-1925 (Pubitemid 41565956)
11. Shibolet O, Regushevskaya E, Brezis M, Soares-Weiser K. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database of Systematic Reviews 2005, Issue 1. [Art. No.: CD004277. DOI: 10.1002/14651858. CD004277.pub2]
12. Targan SR, Feagan BG, Fedorak RN, Lashner BA, Panaccione R, Present DH, et al.Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial. Gastroenterology 2007;132 (5):1672-1683 (Pubitemid 46695722)
13. Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, et al.Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006;354(9):924-33. * Indicates the major publication for the study (Pubitemid 43313659)